Deliver
1 known investors
Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells in patients for cell and gene therapies, targeting cancer immunotherapies as the first indication with applications in autoimmune, neurodegenerative, and cardiovascular diseases.
Investors Β· 1
Frequently asked questions
- What does Deliver do?
- Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells in patients for cell and gene therapies, targeting cancer immunotherapies as the first indication with applications in autoimmune, neurodegenerative, and cardiovascular diseases.
- Who are Deliver's investors?
- Deliver's investors include Deep Science Ventures.